oxonic acid has been researched along with Hypopharyngeal Neoplasms in 11 studies
Oxonic Acid: Antagonist of urate oxidase.
Hypopharyngeal Neoplasms: Tumors or cancer of the HYPOPHARYNX.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The patient was diagnosed as having hypopharyngeal cancer(T4N2cM0)and was treated with concurrent S-1, nedaplatin and radiotherapy(hereafter referred to as SN therapy)." | 7.77 | [A case of hypopharyngeal cancer successfully treated with concurrent S-1, nedaplatin and radiotherapy]. ( Akiyama, R; Egawa, S; Hayashi, T; Ikeda, K; Ikenoya, Y; Kobayashi, S; Sanbe, T; Shimane, T; Sugimoto, A; Uzuki, A, 2011) |
| "Many reports have been published on the treatment for hypopharyngeal cancer, and the treatment modalities and results have become uniform to some extent." | 5.37 | [Efficacy of concurrent chemoradiotherapy with S-1 plus nedaplatin for hypopharyngeal cancer]. ( Egawa, S; Kamakazu, K; Kobayashi, S; Mori, T; Ono, T; Sanbe, T; Shimane, T, 2011) |
| " The patient was diagnosed as having hypopharyngeal cancer(T4N2cM0)and was treated with concurrent S-1, nedaplatin and radiotherapy(hereafter referred to as SN therapy)." | 3.77 | [A case of hypopharyngeal cancer successfully treated with concurrent S-1, nedaplatin and radiotherapy]. ( Akiyama, R; Egawa, S; Hayashi, T; Ikeda, K; Ikenoya, Y; Kobayashi, S; Sanbe, T; Shimane, T; Sugimoto, A; Uzuki, A, 2011) |
| "Many reports have been published on the treatment for hypopharyngeal cancer, and the treatment modalities and results have become uniform to some extent." | 1.37 | [Efficacy of concurrent chemoradiotherapy with S-1 plus nedaplatin for hypopharyngeal cancer]. ( Egawa, S; Kamakazu, K; Kobayashi, S; Mori, T; Ono, T; Sanbe, T; Shimane, T, 2011) |
| "Further examination showed esophageal cancer had metastasized to the cervical lymph nodes and invaded the trachea." | 1.35 | [Safe and successful chemoradiotherapy for a patient with cardiac pacemaker and triple cancers]. ( Hayashi, T; Hirano, N; Hoteya, S; Iizuka, T; Kikuchi, D; Mitani, T; Miyata, Y; Nakamura, M; Ochiai, Y; Sakurada, T; Yahagi, N, 2009) |
| " Regulating the dosage and intervals of S-1 enabled the patients in both cases to survive with cancer as outpatients for 2 years and 2 months after the initial visit (1 year and 10 months from the start of the administration of S-1) in the former case and 3 years from the initial visit (2 years and 1 month from the start of the administration of S-1) in the latter case." | 1.35 | [Two cases of head and neck squamous cell carcinoma in which S-1 administration resulted in long-term sustained QOL]. ( Furuya, A; Kobayashi, S; Monden, T; Mori, T; Ono, T; Sanbe, T; Shimane, T; Suzaki, H, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wakisaka, N | 1 |
| Hirai, N | 1 |
| Kondo, S | 1 |
| Aga, M | 1 |
| Nakanishi, Y | 1 |
| Tsuji, A | 1 |
| Endo, K | 1 |
| Murono, S | 1 |
| Yoshizaki, T | 1 |
| Nakagawa, T | 1 |
| Otsuki, N | 1 |
| Masai, Y | 1 |
| Sasaki, R | 1 |
| Tsukuda, M | 2 |
| Nibu, K | 1 |
| Kikuchi, D | 1 |
| Iizuka, T | 1 |
| Hoteya, S | 1 |
| Miyata, Y | 1 |
| Mitani, T | 1 |
| Ochiai, Y | 1 |
| Sakurada, T | 1 |
| Hirano, N | 1 |
| Hayashi, T | 3 |
| Nakamura, M | 1 |
| Yahagi, N | 1 |
| Shimane, T | 4 |
| Mori, T | 2 |
| Ono, T | 2 |
| Monden, T | 1 |
| Furuya, A | 1 |
| Kobayashi, S | 4 |
| Sanbe, T | 4 |
| Suzaki, H | 2 |
| Abo, H | 1 |
| Matsuda, H | 1 |
| Horiuchi, C | 1 |
| Taguchi, T | 1 |
| Watanabe, M | 1 |
| Niho, T | 1 |
| Egawa, S | 3 |
| Kamakazu, K | 1 |
| Ikeda, K | 2 |
| Akiyama, R | 2 |
| Uzuki, A | 2 |
| Sugimoto, A | 2 |
| Ikenoya, Y | 2 |
| Nakashima, T | 1 |
| Toh, S | 1 |
| Shiratsuchi, H | 1 |
| Yasumatsu, R | 1 |
| Fukushima, J | 1 |
| Nakamura, K | 1 |
| Shioyama, Y | 1 |
| Komune, S | 1 |
| Kajikawa, H | 1 |
| Nario, K | 1 |
| Miyahara, H | 1 |
| Kusuki, M | 1 |
| Iguchi, H | 1 |
| Nakamura, A | 1 |
| Nishiura, H | 1 |
| Kanazawa, A | 1 |
| Yamane, H | 1 |
11 other studies available for oxonic acid and Hypopharyngeal Neoplasms
| Article | Year |
|---|---|
T-status and an oral fluoropyrimidine, S-1, adjuvant chemotherapy are prognostic factors in reduced-RADPLAT for resectable hypopharyngeal cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemoradiotherapy; Chemoth | 2016 |
Additive effects of oral fluoropyrimidine derivative S-1 and radiation on human hypopharyngeal cancer xenografts.
Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Combined Modality Therapy; Drug Comb | 2008 |
[Safe and successful chemoradiotherapy for a patient with cardiac pacemaker and triple cancers].
Topics: Aged; Antimetabolites, Antineoplastic; Combined Modality Therapy; Drug Combinations; Electrocardiogr | 2009 |
[Two cases of head and neck squamous cell carcinoma in which S-1 administration resulted in long-term sustained QOL].
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Drug Combination | 2009 |
[Successful treatment results of S-1 administration in 2 patients, one with a remnant tumor of the larynx and metastatic tumors to the lung, and another with a metastatic tumor in the neck from the hypopharynx].
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cel | 2009 |
[Efficacy of concurrent chemoradiotherapy with S-1 plus nedaplatin for hypopharyngeal cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Humans; Hypopharynge | 2011 |
[Efficacy of concurrent chemoradiotherapy in cases with cervical lymph node metastasis from oropharyngeal or hypopharyngeal cancer].
Topics: Adult; Aged; Aminohydrolases; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Ther | 2011 |
[A case of hypopharyngeal cancer successfully treated with concurrent S-1, nedaplatin and radiotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Combinations; | 2011 |
[Laryngeal preservation for hypopharyngeal cancer by radiotherapy with S-1 and vitamin A(TAR therapy)].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; D | 2012 |
[A case of neck metastasis from hypopharyngeal carcinoma successfully treated with TS-1].
Topics: Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Combin | 2004 |
The syndrome of inappropriate antidiuretic hormone secretion associated with chemotherapy for hypopharyngeal cancer.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; D | 2004 |